Volitionrx Limited (VNRX) Reports In-Line Q1 EPS

Volitionrx Limited (NYSE: VNRX) reported Q1 EPS of ($0.13), in-line with the analyst estimate of ($0.13).

Cash and cash equivalents as of March 31, 2016 totaled $17.0 million, compared with $5.9 million as of December 31, 2015.

For earnings history and earnings-related data on Volitionrx Limited (VNRX) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Bernstein upgrades Analog Devices on Q3 beat, improving risk-reward
• 'We expect salesforce.com (CRM) to capture a meaningful share of next-gen agentic workflows': Cantor